Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARS Pharmaceuticals, Inc. Director's Dealing 2020

Dec 4, 2020

32159_dirs_2020-12-03_281a7d89-7dbe-4943-9fb8-0a860eb4daa3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Silverback Therapeutics, Inc. (SBTX)
CIK: 0001671858
Period of Report: 2020-12-03

Reporting Person: Odegard Valerie (President and CSO)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock option (right to buy) $1.08 2028-07-11 Common Stock (20352) Direct
Stock option (right to buy) $1.08 2028-07-11 Common Stock (1346) Direct
Stock option (right to buy) $2.31 2026-12-14 Common Stock (15406) Direct
Stock option (right to buy) $2.31 2026-12-14 Common Stock (22624) Direct
Stock option (right to buy) $1.27 2030-04-28 Common Stock (60806) Direct
Stock option (right to buy) $1.27 2030-04-28 Common Stock (47311) Direct
Stock option (right to buy) $1.27 2030-04-28 Common Stock (49054) Direct
Stock option (right to buy) $6.65 2030-09-30 Common Stock (61944) Direct

Footnotes

F1: The shares shall vest in 48 equal monthly installments starting on July 1, 2018.

F2: 50% of the shares vested on November 1, 2018 and the remaining shares vested on March 1, 2019.

F3: 25% of the shares vested on October 24, 2017 and the remaining shares vested in 36 equal monthly installments thereafter.

F4: 25% of the shares vested on May 16, 2018 and the remaining shares shall vest in 36 equal monthly installments thereafter.

F5: 25% of the shares shall vest on March 4, 2021 and the remaining shares shall vest in 36 equal monthly installments thereafter.

F6: 25% of the shares shall vest on July 1, 2021 and the remaining shares shall vest in 36 equal monthly installments thereafter.

F7: The shares shall vest in 36 equal monthly installments beginning on October 18, 2020.

F8: The shares shall vest in 48 equal monthly installments beginning on October 22, 2020.